Page 2 - Cannabis News Florida Novemebr 2019

Medical

Marijuana
Insurance for

Physicians and
Dispensaries

Strainprint Patient Retrospective Report Connects It’s a common misconception that
legal marijuana dispensary insurance
Product Chemical Profile to Symptom Efficacy is very expensive and unattainable, but
it is actually very reasonably priced.
We can provide you with many types
Canadian cannabis analytics company The specific details of the report reveal several key of comprehensive insurance coverage
Strainprint Technologies launches ground- insights. Perhaps the most striking is that many differ- which will help your business stay on
breaking medical cannabis patient retrospec- ent cannabis species are offering patients comparable its feet should some type of calamity or
tive report. The report summarizes key take- relief, meaning that the efficacy of a particular strain is unfortunate event arise.
aways and results based on over 805,000 based on more than just selected species or the THC-to-
patient outcomes. CBD ratio. What’s also interesting is that the data reveals • General Liability
the legalization of recreational cannabis use isn’t chang- • Property Protection
Who Benefits from the Report? ing how or when patients treat their symptoms. • Medicine Coverage
The report supports the medical cannabis While there hasn’t been a change in that behaviour, • Business Income
• Extra Expense Insurance
ecosystem in the following ways: patients are still overwhelmingly reporting either neu- • Product Liability
• The report guides retailers and licensed tral or positive emotional effects from their medical
producers to optimize their products and cannabis use with very few reports of any negative expe- Danna-Gracey is the leading indepen-
services to better meet customer needs. riences. dent medical malpractice insurance
• Clinicians and the broader medical com- BY JACK CHOROS The preferred way to administer medical cannabis agency in Florida, and the top agency
munity can gain a better understanding of varies based on the age and geographic location of the for several of the lead-
patient behaviour and make better recom- patient while the most effective methods vary by both ing insurers in Florida.
mendations for treatment based on the data. age and gender. For more information
• The Consumer Packaged Goods industry can utilize the The report confirms that muscle and joint pain, anxiety, depres- contact Jessica Hoehn
research in the development of new products. sion and insomnia are still the most common symptoms patients of Danna-Gracey at
888.496.0059.
• Financial institutions can gain a greater understanding of how are treating using medical cannabis. Patients over 45 years of age
products are being used in the market, which ultimately impact are more likely to use it for joint pain while those under 45 are
consumers both as medical cannabis users and banking cus- likely treating anxiety or muscle pain.
tomers. A free preview of The Canadian Medical Cannabis Experience:
• Governments and public health organizations can gain A 2019 Retrospective is available now, with the full report avail-
insights that will help create improved policies, guiding physi- able for purchase at strainprint.ca/spt-reports/the-canadian-med-
cians and pharmacists. ical-cannabis-report/ . 888.496.0059 • Jessica@dannagracey.com
www.dannagracey.com

Cannabis News Florida cannabisnewsflorida.com November 2019 43